Page 190 - அமெரிக்கன் கல்லூரி ஆஃப் மகப்பேறியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Print this article Health providers will be permitted temporarily to mail abortion-inducing medications to patients without seeing them in person, the Food and Drug Administration announced Tuesday, reversing a Trump administration policy. “By halting enforcement of the in-person dispensing requirement during the COVID-19 pandemic, the FDA is recognizing and responding to the available evidence which has clearly and definitively demonstrated that the in-person dispensing requirement for mifepristone is unnecessary and restrictive,” said the American College of Obstetricians and Gynecologists, a medical organization representing roughly 90% of gynecologists and obstetricians in the United States. Acting FDA Commissioner Janet Woodcock told the ACOG in a letter published Monday that the agency had not found evidence to support the rule that women have to see their healthcare providers in person to be prescribed the abortion medication mifepristone. The ACOG pressured the FDA

United statesJanet woodcockAmerican college of obstetriciansDrug administrationAmerican collegeஒன்றுபட்டது மாநிலங்களில்ஜேனட் மரக்கட்டைஅமெரிக்கன் கல்லூரி ஆஃப் மகப்பேறியல்அமெரிக்கன் கல்லூரி